Anavex Life Sciences Corp.: Form 8-K, filed Sep 28, 2026
Filed with the SEC on Sep 28, 2026 and accepted by EDGAR at Sep 28, 2026, 21:27 ET.
Items reported
- Item 5.01 Change in control
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001731122-26-001294. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.